Sexual minority women have a higher risk of postpartum depression but are less likely to have their sexual identities documented in electronic medical records, according to a Northwestern Medicine study published in JAMA Psychiatry.
Browsing: Clinical Breakthroughs
Combining immunotherapy with a tumor-targeted virus may help extend survival in some patients with recurrent glioblastoma, according to the results of a trial published in Nature Medicine.
Northwestern Medicine scientists have developed a new cellular model of uterine fibroids that stem from a common genetic mutation, which will accelerate further research and treatment development, according to findings published in Nature Communications.
A new drug used to treat cancer may also prevent allergic reactions to peanuts, according to a study published in the Journal of Clinical Investigation.
Time-restricted eating without calorie counting was as effective as a calorie restriction diet for weight loss and cardiometabolic risk reduction in obese adults, according to findings published in Annals of Internal Medicine.
Testing performance of rapid antigen tests for SARS-CoV-2 improved for both asymptomatic and symptomatic patients after testing multiple times in 48-hour intervals, according to findings published in the Annals of Internal Medicine.
Despite having risk factors for heart disease, only 60 percent of women reported receiving counseling on optimizing their heart health at their six-week postpartum visits, according to a new Northwestern study.
Pregnant people who report feeling unsafe in their neighborhoods are more likely to experience depression during pregnancy and have a baby with low birth weight, according to a study published in JAMA Network Open.
Metformin, a drug commonly used to treat diabetes, may prevent the development of “long COVID,” according to a clinical trial published in The Lancet Infectious Diseases.
A single infusion of CAR T-cell therapy induced complete response or remission in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma, according to a recent clinical trial published in The Lancet.